Viewing Study NCT01634061

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 12:57 PM

Ignite Modification Date: 2026-01-07 @ 4:04 PM

Study NCT ID: NCT01634061

Status: COMPLETED

Last Update Posted: 2020-12-09

First Post: 2012-06-26

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

Sponsor: Novartis Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module